T2 Biosystems, Inc.·4

Feb 23, 7:22 PM ET

Giffin Brett A. 4

4 · T2 Biosystems, Inc. · Filed Feb 23, 2022

Insider Transaction Report

Form 4
Period: 2022-02-20
Giffin Brett A.
Chief Commercial Officer
Transactions
  • Award

    Restricted Stock Units

    2022-02-20+200,000200,000 total
    Common Stock (200,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The restricted stock units vest in three equal annual installments commencing on February 20, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION